MedPath
FDA Approval

Docusate Sodium

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
McKesson Corporation
DUNS: 140529962
Effective Date
April 22, 2025
Labeling Type
HUMAN OTC DRUG LABEL
Docusate(100 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Contract Packaging Resources Inc.

McKesson Corporation

McKesson Corporation dba SKY Packaging

960203917

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Docusate Sodium

Product Details

NDC Product Code
63739-478
Application Number
505G(a)(3)
Marketing Category
OTC Monograph Drug (C200263)
Route of Administration
ORAL
Effective Date
April 22, 2025
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1AClass: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
SORBITOLInactive
Code: 506T60A25RClass: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8Class: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
GLYCERINInactive
Code: PDC6A3C0OXClass: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327LClass: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOAClass: IACT
DocusateActive
Code: F05Q2T2JA0Class: ACTIBQuantity: 100 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath